Cristiane C. K. Mayerhofer

Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure.

T. Ueland, P. Aukrust, J. Hov, 2017, Journal of cardiac failure.

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

T. Ueland, A. Svardal, P. Aukrust, 2020, ESC heart failure.

Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts.

T. Ueland, M. Kummen, J. Hov, 2018, Journal of the American College of Cardiology.

Lesion Complexity and€Prolonged Antiplatelet Therapy

T. Ueland, M. Kummen, J. Hov, 2018 .

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

S. Halvorsen, A. Svardal, P. Aukrust, 2021, EBioMedicine.

The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.

G. Dellgren, K. Karason, T. Ueland, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure

J. Hov, K. Broch, A. Awoyemi, 2019, ESC heart failure.

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

S. Halvorsen, P. Aukrust, J. Hov, 2018, ESC heart failure.

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure

J. Hov, I. Seljeflot, K. Holm, 2023, Frontiers in Cardiovascular Medicine.